Skip to content
View rushadnihal's full-sized avatar
  • Joined Oct 30, 2026

Block or report rushadnihal

Block user

Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users.

You must be logged in to block users.

Content in all repositories owned by your account will be closed.
Maximum 250 characters. Please don’t include any personal information such as legal names or email addresses. This note will only be visible to you.
Report abuse

Contact GitHub support about this user’s behavior. Learn more about reporting abuse.

Report abuse
rushadnihal/README.md

Hi, I'm Rushad Nihal

Biostatistician with an M.S. in Biostatistics (Arizona State University) and a B.Tech in Biotechnology. I work where statistics meets biology: turning messy clinical, omics and bioprocess data into analyses that are reproducible and honest about what they can and cannot show.


Two results I'm proud of

A biomarker that held up on data it never saw. A frozen clinical + 5-gene signature for lung adenocarcinoma, built with every data-dependent step refit inside each training fold, then tested without refitting on two independent cohorts: Harrell C 0.715 (n=226) and 0.697 (n=442). Inside TCGA, multi-omics did not detectably beat a clinical-only model, and the repo reports that as the pre-specified result rather than hiding it. → multi-omics-biomarker-pipeline

A target trial emulation that ends in an honest null. ACEi/ARB use and cardiovascular death in type 2 diabetes with CKD (NHANES 2005-2018, n=2,540). After weighting, covariate balance is good (largest SMD 0.051), but the estimates are inconclusive. The project diagnoses why (residual healthy-user bias, limited sample size) and checks its machinery against simulations with a known truth. → causal-survival-analysis


What I work on

  • Survival analysis and biomarkers: leakage-controlled modeling of high-dimensional omics data, with frozen signatures and external validation.
  • Causal inference: target trial emulation, inverse-probability weighting, g-formula and competing-risks methods on observational health data.
  • Multilevel and clinical-trial data: mixed-effects models for clustered and longitudinal data, including cluster randomized trials.
  • Bioprocess optimization: response surface methodology and design of experiments for fermentation media, so fewer wet-lab runs answer more questions.
  • Reproducible research: pipelines that rebuild every table and figure from raw data, with tests and recorded checksums.

Selected projects

Project What it is Stack
multi-omics-biomarker-pipeline Leakage-controlled survival biomarker for lung adenocarcinoma (TCGA-LUAD), validated on two external cohorts Python
causal-survival-analysis Target trial emulation of ACEi/ARB use and cardiovascular death in type 2 diabetes with CKD, using NHANES Python
aact-trial-outcomes-sql-sas What predicts early termination and late or missing results reporting in 44k Phase 2/3 drug trials on ClinicalTrials.gov (AACT): PostgreSQL cohort build, then SAS logistic and Cox models with sponsor-clustered errors SQL, SAS
cdisc-pilot-sas-adam-tlf SDTM to ADaM to tables, Kaplan-Meier/Cox and a repeated measures model on the public CDISC pilot study, with the derived datasets checked against the published PHUSE ADaM files (PROC COMPARE) SAS
myco-rsm Response surface and multi-objective media optimizer for submerged mycelial fermentation R, Shiny
adni-subgroup-calibration-code Work in progress: audit of how well MCI-to-dementia risk models are calibrated across landmark times and demographic subgroups in ADNI (code only; ADNI data cannot be redistributed) R

Toolbox

Languages: Python, R, SQL, SAS Python: pandas, scikit-learn, scikit-survival, lifelines, statsmodels R: tidyverse, caret, survival, nlme, lme4, rsm, Shiny, Quarto Methods: survival analysis, causal inference, mixed-effects models, design of experiments, time-series forecasting, supervised machine learning Lab background: microbiology, molecular biology, PCR, bioprocess protocols, quality control

Background

  • M.S. Biostatistics, Arizona State University (2025, GPA 3.97/4.00)
  • B.Tech Biotechnology, Manipal Institute of Technology (2023)
  • Data Science Analyst on a collaboration between ASU and the Global Observatory for Physical Activity (GoPA!): built a country-year panel from physical-activity publication records and socioeconomic indicators for six African countries, compared naive-drift, ETS and ARIMA forecasts to 2030, and screened predictors with correlation, PCA and lagged cross-correlation (GoPA! data are confidential and not shared)
  • iGEM with the Manipal team: Bronze (2021) and Gold (2022)

Currently

Writing up a calibration audit of dementia risk prediction in ADNI, and learning German (A1).

Get in touch

Email is the best way to reach me: rushadisatwork@gmail.com

Pinned Loading

  1. oasis2-mmrm-trial-simulation oasis2-mmrm-trial-simulation Public

    MMRM natural-history analysis of OASIS-2 brain volume, SAS/R cross-check, and trial simulation study.

    R

  2. aact-trial-outcomes-sql-sas aact-trial-outcomes-sql-sas Public

    Reproducible SQL + SAS analysis of ClinicalTrials.gov (AACT, 2026-11-15 snapshot): what predicts early termination and late or missing results reporting in 44k interventional Phase 2/3 drug trials.…

    SAS 1

  3. cdisc-pilot-sas-adam-tlf cdisc-pilot-sas-adam-tlf Public

    SDTM to ADaM to TLFs in SAS for the public CDISC pilot study (CDISCPilot01): ADSL/ADAE/ADTTE derivation, QC against PHUSE ADaM with PROC COMPARE, tables, Kaplan-Meier and Cox, and a PROC MIXED repe…

    Rich Text Format 1

  4. ADNI-Subgroup-Calibration-code ADNI-Subgroup-Calibration-code Public

    R code for a landmark audit of MCI-to-dementia risk prediction in ADNI: calibration by landmark time, protocol era and demographic subgroup. Working draft; ADNI data not included.

    R 1

  5. causal-survival-analysis causal-survival-analysis Public

    Target trial emulation of ACEi/ARB and cardiovascular mortality in type 2 diabetes with CKD (NHANES + NCHS linked mortality)

    Python 1

  6. multi-omics-biomarker-pipeline multi-omics-biomarker-pipeline Public

    Leakage-controlled multi-omics survival biomarker pipeline for TCGA-LUAD with frozen signature and external validation

    Python 1